Steven M. Dunn

1.7k total citations
25 papers, 923 citations indexed

About

Steven M. Dunn is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Steven M. Dunn has authored 25 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in Steven M. Dunn's work include Monoclonal and Polyclonal Antibodies Research (10 papers), CAR-T cell therapy research (9 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Steven M. Dunn is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), CAR-T cell therapy research (9 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Steven M. Dunn collaborates with scholars based in Switzerland, United States and United Kingdom. Steven M. Dunn's co-authors include Bent K. Jakobsen, Tara Mahon, Yangbing Zhao, Paul F. Robbins, Alan Bennett, Zhili Zheng, Steven A. Rosenberg, Peter Molloy, Ruth Moysey and Yi Li and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Immunology.

In The Last Decade

Steven M. Dunn

24 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven M. Dunn Switzerland 13 618 605 238 186 163 25 923
Nadja Bulbuc Germany 8 271 0.4× 606 1.0× 271 1.1× 97 0.5× 97 0.6× 9 870
Annelies Jorritsma Netherlands 12 776 1.3× 671 1.1× 320 1.3× 62 0.3× 334 2.0× 16 1.1k
J A Titus United States 19 431 0.7× 848 1.4× 505 2.1× 652 3.5× 142 0.9× 30 1.4k
Rodrigo Vazquez-Lombardi Australia 14 221 0.4× 377 0.6× 359 1.5× 359 1.9× 58 0.4× 17 846
Nachimuthu Chinnasamy United States 15 617 1.0× 460 0.8× 611 2.6× 38 0.2× 475 2.9× 21 1.2k
Hieu Nguyen United States 8 620 1.0× 600 1.0× 226 0.9× 33 0.2× 132 0.8× 10 955
Linda Pan United States 11 522 0.8× 895 1.5× 444 1.9× 80 0.4× 106 0.7× 23 1.1k
Wayne Aldrich United States 19 419 0.7× 590 1.0× 501 2.1× 100 0.5× 262 1.6× 46 1.1k
Sachiko Okamoto Japan 15 644 1.0× 482 0.8× 578 2.4× 43 0.2× 285 1.7× 37 1.2k
Steve Burke United States 9 437 0.7× 352 0.6× 281 1.2× 493 2.7× 56 0.3× 15 832

Countries citing papers authored by Steven M. Dunn

Since Specialization
Citations

This map shows the geographic impact of Steven M. Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Dunn more than expected).

Fields of papers citing papers by Steven M. Dunn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Dunn. The network helps show where Steven M. Dunn may publish in the future.

Co-authorship network of co-authors of Steven M. Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Dunn. A scholar is included among the top collaborators of Steven M. Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Dunn. Steven M. Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Croce, Giancarlo, Sara Bobisse, Maiia E. Bragina, et al.. (2025). Phage display enables machine learning discovery of cancer antigen–specific TCRs. Science Advances. 11(24). eads5589–eads5589. 2 indexed citations
2.
Kosti, Paris, et al.. (2025). Potent and durable control of mesothelin-expressing tumors by a novel T cell-secreted bi-specific engager. Journal for ImmunoTherapy of Cancer. 13(3). e010063–e010063.
3.
Gnesin, Silvano, Nicolas Chouin, Michel Chérel, et al.. (2023). From bench to bedside: 64Cu/177Lu 1C1m-Fc anti TEM-1: mice-to-human dosimetry extrapolations for future theranostic applications. EJNMMI Research. 13(1). 59–59. 1 indexed citations
4.
Atsaves, Vassilios, et al.. (2022). A cell-based phenotypic library selection and screening approach for the de novo discovery of novel functional chimeric antigen receptors. Scientific Reports. 12(1). 1136–1136. 8 indexed citations
5.
Faivre-Chauvet, Alain, Jacques Barbet, Niklaus Schaefer, et al.. (2021). Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model. Pharmaceutics. 13(1). 96–96. 12 indexed citations
6.
Atsaves, Vassilios, et al.. (2021). Soluble trivalent engagers redirect cytolytic T cell activity toward tumor endothelial marker 1. Cell Reports Medicine. 2(8). 100362–100362. 12 indexed citations
7.
Faivre-Chauvet, Alain, Silvano Gnesin, Niklaus Schaefer, et al.. (2020). 177Lu radiolabeling and preclinical theranostic study of 1C1m-Fc: an anti-TEM-1 scFv-Fc fusion protein in soft tissue sarcoma. EJNMMI Research. 10(1). 98–98. 14 indexed citations
8.
Gano, Lurdes, Rita Melo, Filipa Mendes, et al.. (2020). Biological evaluation of new TEM1 targeting recombinant antibodies for radioimmunotherapy: In vitro, in vivo and in silico studies. European Journal of Pharmaceutics and Biopharmaceutics. 158. 233–244. 5 indexed citations
9.
Dargitz, Carl, et al.. (2020). Rotea: a closed and automated instrument for efficient cell isolation, washing and conentration in cell therapy workflows. Cytotherapy. 22(5). S200–S200. 4 indexed citations
10.
Coukos, George, et al.. (2019). Integrating SpyCatcher/SpyTag covalent fusion technology into phage display workflows for rapid antibody discovery. Scientific Reports. 9(1). 12815–12815. 16 indexed citations
11.
Bonvin, Pauline, Christopher Power, Amanda E. I. Proudfoot, & Steven M. Dunn. (2015). Mutagenesis by Phage Display. Methods in enzymology on CD-ROM/Methods in enzymology. 570. 187–205. 1 indexed citations
12.
Bonvin, Pauline, Steven M. Dunn, François Rousseau, et al.. (2014). Identification of the Pharmacophore of the CC Chemokine-binding Proteins Evasin-1 and -4 Using Phage Display. Journal of Biological Chemistry. 289(46). 31846–31855. 23 indexed citations
13.
Li, Chunsheng, Junying Wang, Jia Hu, et al.. (2014). Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer. Oncotarget. 5(16). 6994–7012. 13 indexed citations
14.
Moysey, Ruth, Yi Li, Samantha Paston, et al.. (2010). High affinity soluble ILT2 receptor: a potent inhibitor of CD8+ T cell activation. Protein & Cell. 1(12). 1118–1127. 7 indexed citations
15.
Robbins, Paul F., Yong F. Li, Mona El‐Gamil, et al.. (2008). Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions. The Journal of Immunology. 180(9). 6116–6131. 252 indexed citations
16.
Varela‐Rohena, Angel, Peter Molloy, Steven M. Dunn, et al.. (2008). Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nature Medicine. 14(12). 1390–1395. 197 indexed citations
17.
Cole, David K., Steven M. Dunn, Malkit Sami, et al.. (2008). T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding. Molecular Immunology. 45(9). 2700–2709. 36 indexed citations
18.
Zhao, Yangbing, Alan Bennett, Zhili Zheng, et al.. (2007). High-Affinity TCRs Generated by Phage Display Provide CD4+ T Cells with the Ability to Recognize and Kill Tumor Cell Lines. The Journal of Immunology. 179(9). 5845–5854. 164 indexed citations
19.
Dunn, Steven M., P.J. Rizkallah, Emma Baston, et al.. (2006). Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide‐MHC without increasing apparent cross‐reactivity. Protein Science. 15(4). 710–721. 86 indexed citations
20.
Dunn, Steven M., P.C.E. Moody, J. Allan Downie, & William V. Shaw. (1996). Crystallization and preliminary diffraction studies of NodL, a rhizobial O‐acetyl‐transferase involved in the host‐specific nodulation of legume roots. Protein Science. 5(3). 538–541. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadja Bulbuc Breakdown of academic impact, for papers by Annelies Jorritsma Breakdown of academic impact, for papers by J A Titus Breakdown of academic impact, for papers by Rodrigo Vazquez-Lombardi Breakdown of academic impact, for papers by Nachimuthu Chinnasamy Breakdown of academic impact, for papers by Hieu Nguyen Breakdown of academic impact, for papers by Linda Pan Breakdown of academic impact, for papers by Wayne Aldrich Breakdown of academic impact, for papers by Sachiko Okamoto Breakdown of academic impact, for papers by Steve Burke
Rankless by CCL
2026